Speaker illustration

Professor Wai Hong Wilson Tang

Cleveland Clinic, Cleveland (United States of America)

Member of:

Heart Failure Association

Dr. Tang is Professor of Medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. As a practicing heart failure/transplant cardiologist at the Cleveland Clinic specialized in cardiomyopathies, cardio-renal diseases, and cancer-related heart disease, Dr. Tang’s primary research interest is to investigate how the heart interacts with other organs in the setting of heart failure. Dr. Tang’s translational research focuses on understanding the mechanisms through which inflammation, oxidation, and nitrative stress contribute to disease progression in heart failure and cardiomyopathy in humans. Inducted into American Society of Clinical Investigation in 2013 and Association for American Physicians in 2018, Dr. Tang’s recent research efforts have unraveled the contributions of novel intestinal microbiota-related metabolomic pathways in human heart failure and renal failure pathogenesis.

Phase 1b evaluation of safety and activity of JK07 in heart failure with reduced ejection fraction

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Late breaking clinical trials: chronic HF and cardiomyopathies


A patient with HFpEF and renal dysfunction

Event: Heart Failure 2018

Topic: Chronic Heart Failure

Session: Guidelines in daily practice V - HFpEF


Targeting at-risk phenotypes

Event: Heart Failure 2018

Topic: Acute Heart Failure, Other

Session: Prevention remains the best treatment in heart failure


State of the Art: treatment of renal dysfunction in heart failure

Event: ESC Congress 2017

Topic: AHF - Assessment and diagnosis

Session: Renal dysfunction and iron deficiency: facts, myths, and solutions


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb